Opendata, web and dolomites

MITrep

Automated mini-invasive surgical approach to the treatment of mitral insufficiency

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MITrep project word cloud

Explore the words cloud of the MITrep project. It provides you a very rough idea of what is the project "MITrep" about.

once    ambition    heavy    specialist    afflicts    mitrep    efficiency    leak    unbearable    abnormally    nov    driver    feasibility    skilled    racing    fragile    palpitations    cmi    operation    age    death    patented    affix    starting    invasive    fatigue    mini    surgeries    anchored    80k    gold    75    tricuspid    elderly    goes    halve    healthcare    double    days    moderate    reduce    stroke    patients    device    chronic    times    improvement    returns    prevalence    tagged    lack    worldwide    mitral    valvuloplasty    half    heart    annuloplasty    insufficiency    300    tested    preventing    sudden    risk    care    patient    hospital    trial    inoperable    icu    80    ring    usa    company    surgery    rate    leaking    hours    safety    intensive    automatically    standard    10    symptoms    30k    severe    hospitalization    normal    2030    shortness    error    surgical    breath    replicable    vs    repair    surgeons    context    time    dramatic    deployment    mainly    valve    holds    followed    validate    first    aortic    transapical    blood    operations    aged    uses    post    transfemoral   

Project "MITrep" data sheet

The following table provides information about the project.

Coordinator
CMI NOV 

Organization address
address: BATIMENT 4 PUISSANCE 3 ZA CHAVANON
city: MONISTROL SUR LOIRE
postcode: 43120
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.cmi-nov.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CMI NOV FR (MONISTROL SUR LOIRE) coordinator 50˙000.00

Map

 Project objective

Mitral valve insufficiency is a heart condition, where blood is abnormally leaking out of the mitral valve. This condition mainly afflicts the elderly patients: - 80% of patients aged 80 show moderate symptoms (chronic fatigue, shortness of breath, palpitations, racing heart rate) - 10% of patients above 75 with severe symptoms are at risk of a sudden death (stroke) within 5 years. - Prevalence will double by 2030. Mitral insufficiency is treated with open heart surgery (300,000 operations/year in the EU and the USA) followed by intensive care. But this operation is unbearable for fragile patients. Half of the patients above 75 are tagged inoperable because of their age. Less invasive repair surgeries have been tested (annuloplasty by transfemoral surgery) but lack efficiency and safety and require highly skilled surgeons (not available in each hospital). In this context, the company CMI’nov has developed MITrep, the first patented mini-invasive surgical device that automatically goes to the mitral valve with no trial and error to affix a leak-preventing ring on the valve. It uses the transapical approach. Once the ring is anchored, the mitral valve returns to normal activity. No heavy post-surgery effects are expected. No intensive care required.

MITrep can be used by any surgeons : no need to be a mitral valve specialist. It will allow to halve the operation time (from 5 hours to less than 2 hours), reduce hospitalization time to 3 days (vs 5-8 days with 2 days in ICU) and cost about three times less than open heart surgery (30k€ vs 80k€). It means a dramatic cost reduction for healthcare systems and a real improvement of the care of the elderly patient.

This project holds the ambition to build a new gold standard in valvuloplasty worldwide, starting with mitral repair and replicable to aortic and tricuspid valve repair. It is also a value driver for CMI’nov. The Phase 1 project will validate the feasibility of MITrep before scale-up and deployment.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MITREP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MITREP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

GREEN WHS (2019)

NATURE FRIENDLY WATER HYDRAULIC STEERING SYSTEM

Read More  

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More  

TuneFork (2018)

Mobile technology that brings personalized audio into your life

Read More